nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus
|
Chou, Sunwen |
|
2018 |
157 |
C |
p. 128-133 |
artikel |
2 |
CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDS
|
Tian, Ren-Rong |
|
2018 |
157 |
C |
p. 9-17 |
artikel |
3 |
Construction of an attenuated goatpox virus AV41 strain by deleting the TK gene and ORF8-18
|
Zhu, Yilong |
|
2018 |
157 |
C |
p. 111-119 |
artikel |
4 |
Editorial Board
|
|
|
2018 |
157 |
C |
p. ii |
artikel |
5 |
Establishment of a reverse genetics system for duck Tembusu virus to study virulence and screen antiviral genes
|
Chen, Shun |
|
2018 |
157 |
C |
p. 120-127 |
artikel |
6 |
Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice
|
Hawman, David W. |
|
2018 |
157 |
C |
p. 18-26 |
artikel |
7 |
Formation of the Asian Rabies Control Network (ARACON): A common approach towards a global good
|
Coetzer, Andre |
|
2018 |
157 |
C |
p. 134-139 |
artikel |
8 |
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
|
Lackenby, Angie |
|
2018 |
157 |
C |
p. 38-46 |
artikel |
9 |
Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential
|
Heinimäki, Suvi |
|
2018 |
157 |
C |
p. 1-8 |
artikel |
10 |
Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro-viral factor and antiviral target for New World arenaviruses
|
Dunham, Eric C. |
|
2018 |
157 |
C |
p. 140-150 |
artikel |
11 |
Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein
|
Meutiawati, Febrina |
|
2018 |
157 |
C |
p. 68-79 |
artikel |
12 |
Recombinant mutagenic 3ABC protein and monoclonal antibody for quality-control testing in foot-and-mouth disease vaccines
|
González, Adriana Sierra |
|
2018 |
157 |
C |
p. 93-101 |
artikel |
13 |
Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses
|
Lundberg, Lindsay |
|
2018 |
157 |
C |
p. 57-67 |
artikel |
14 |
Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics
|
Schafer, Adam |
|
2018 |
157 |
C |
p. 47-56 |
artikel |
15 |
The clinically approved MEK inhibitor Trametinib efficiently blocks influenza A virus propagation and cytokine expression
|
Schräder, Tobias |
|
2018 |
157 |
C |
p. 80-92 |
artikel |
16 |
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
|
Todt, Daniel |
|
2018 |
157 |
C |
p. 151-158 |
artikel |
17 |
The second-generation thiazolide haloxanide is a potent inhibitor of avian influenza virus replication
|
La Frazia, Simone |
|
2018 |
157 |
C |
p. 159-168 |
artikel |
18 |
TLR7 polymorphism, sex and chronic HBV infection influence plasmacytoid DC maturation by TLR7 ligands
|
Buschow, Sonja I. |
|
2018 |
157 |
C |
p. 27-37 |
artikel |
19 |
Vaccination with RSV M209-223 peptide promotes a protective immune response associated with reduced pulmonary inflammation
|
Fazolo, Tiago |
|
2018 |
157 |
C |
p. 102-110 |
artikel |